A new standard of care in image-guided therapy
Topics
At a glance
Needs As demand increases for image-guided therapy, there is a need for:
Solution Philips Azurion is an image-guided therapy platform that can be used to diagnose and treat patients in hospitals or specialist clinics, supporting diagnostic, interventional and minimally invasive surgery across vascular, non-vascular, cardiovascular and neuro procedures.
Benefits
Share on social media
Philips Azurion is an image-guided therapy platform that allows physicians to provide superior care, easily and confidently perform procedures, whilst optimizing lab productivity.
Faced with a growing demand for image-guided therapy and increasingly complex procedures, hospitals and clinics are looking for ways to treat more patients in less time without compromising quality of care. Developed in close collaboration with leading hospitals, Philips Azurion is an image-guided therapy platform that is designed to provide clinicians the control and information they need to perform procedures efficiently while delivering superior care for patients. An independently verified study at St. Antonius Hospital in The Netherlands shows that Philips Azurion enabled a 17% reduction in procedure times, a 12% reduction of in-lab patient preparation time, and a 28% reduction of postprocedure lab time — allowing them to treat 1 more patient per day[1].
The rise of image-guided therapies
As healthcare systems around the world are facing rising patient volumes and increasing cost pressures, the number and complexity of image-guided therapy procedures is growing. Image-guided therapies, also known as minimally invasive therapies or interventions, are usually performed by delivering a local treatment via catheters, navigated through a small opening in the blood vessels, or needles through the skin. Medical imaging technologies involving X-rays, ultrasound, CT and MRI are used to enable and guide these procedures. The images produced provide the visual maps that allow the clinician to guide these instruments through the body to perform the therapy. The ongoing growth of image-guided therapy procedures is being driven by the significant benefits it offers healthcare systems and patients. Those benefits include: • Enhanced procedural outcome[2] • Reduced patient risk[2] • Shorter recovery times and hospital stays[2] • Lower health system costs[2]
Supporting a wide range of procedures
Harnessing procedural information from various sources, such as imaging systems, interventional devices, navigation tools, and patient health records, Azurion is designed to anticipate what clinicians need, when they need it – to make procedures flow intuitively and easily. Azurion enables clinicians to provide superior care through pre-programmed, personalized settings to help minimize preparation errors, and features high quality imaging at low radiation exposure. The platform delivers an intuitive user experience that empowers clinicians to move quickly and confidently through procedures. Clinicians have instant access to patient data, resulting in less walking between the exam room and the control room – which can reduce the need for sterility breaks[3] and lower infection risks[4]. Philips consultants can help to make further gains in the efficiency and quality of the care delivery process, based on data and workflow analysis.
Philips has been pioneering the use of minimally invasive therapies for 60 years. Developed in close collaboration with our clinical partners, Azurion is an image-guided therapy platform that supports a wide range of procedures – from PCI (percutaneous coronary intervention) procedures to complex vascular perfusion exams.
Reducing preparation and procedure times
Sources: [1] Results are specific to the institution where they are obtained and may not reflect the results achievable at other institutions. [2] Helmberger T, Martí-Bonmatí L, Pereira P, et al. Insights Imaging. 2013;4:1–7 [3] Mangram AJ, Horan TC, Pearson ML, et al. The Hospital Infection Control Practices Advisory Committee. Guideline for Prevention of Surgical Site Infection, Am J Infect Control.1999;27:97–134 [4] Alexander JW, Solomkin JS, Edwards MJ. Updated Recommendations for Control of Surgical Site Infections. Annals
St. Antonius Hospital in the Netherlands participated in a two-year study into the impact of Philips Azurion and its clinical workflow on their interventional vascular department. The independently verified study shows that clinicians’ use of Azurion led to significant time savings, including a 17% reduction of the average interventional procedure time, a 12% reduction of inlab patient preparation time, and a 28% reduction of post-procedure lab time. This allows St. Antonius Hospital to treat one more patient per day, to help hundreds more patients each year.[1]
Share on social media
